Tonix Pharmaceuticals Holding Corp (TNXP)
NASDAQ · Healthcare
Tonix Pharmaceuticals Holding Corp Net Income 2023–2025
Tonix Pharmaceuticals Holding Corp annual/quarterly net income history and growth rate from 2023 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Tonix Pharmaceuticals Holding Corp net income for the quarter ending March 31, 2026 was -40.2 M, a 138.84% increase year-over-year.
- Tonix Pharmaceuticals Holding Corp net income for the twelve months ending March 31, 2026 was -117.3 M, a 13.68% decrease year-over-year.
- Tonix Pharmaceuticals Holding Corp annual net income for 2025 was -124.0 M, a 4.63% decrease from 2024.
- Tonix Pharmaceuticals Holding Corp annual net income for 2024 was -130.0 M, a 11.47% increase from 2023.
- Tonix Pharmaceuticals Holding Corp annual net income for 2023 was -116.7 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Tonix Pharmaceuticals Holding Corp Net Income — FAQ
Tonix Pharmaceuticals Holding Corp (TNXP) net income over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is Tonix Pharmaceuticals Holding Corp's net income?
Tonix Pharmaceuticals Holding Corp (TNXP) reported net income of -$124M for fiscal 2025.
Where can I see TNXP's net income history?
The chart and table above show Tonix Pharmaceuticals Holding Corp's net income by year and by quarter, including the growth rate.